Home › Studies › PRJNA387903
PRJNA387903 SRP107965

Long. virome study in Finnish/Estonian children with T1D

Intestinal Virome Changes Precede Autoimmunity in Type I Diabetes Susceptible Children

Cohort-longitudinal study of 220 gut virome samples from children in Finland (Jorvi) and Estonia (Tartu), comparing 163 healthy-control samples with 57 type 1 diabetes samples to examine virome changes preceding autoimmunity. machine-written summary

220 samples · 220 runs · FI, EE · Infant / toddler · 2017 · 0.47 Gbp / sample

Sources
✓Sequence archive 609○Abstract / description○Full text✓Supplementary tables 440✓External resources 660–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive609 sample values (age, country, subject id)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC10904392, PMC13434738
✓ Supplementary tables440 sample values (diet, timepoint)
✓ External resources660 sample values (health condition, health condition detail, sex) · from GMrepo v3
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
2 countries
Age
infant169
unknown51
Condition
healthy_control163
type1_diabetes57
Sex
male111
female109
Country
FI169
EE51
Body site
primary220
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 1 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 52 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 160 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 7 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.47 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

22 of 22 people sampled more than once (220 samples; median 10, up to 16 per person) · follow-up median 14 mo (max 19 mo) · median interval between samples 33 d (time from age at collection).

1.11.1: day 01.1: day 301.1: day 621.1: day 921.1: day 1532.12.1: day 02.1: day 202.1: day 622.1: day 912.1: day 1252.1: day 1512.1: day 1812.1: day 2143.23.2: day 03.2: day 923.2: day 1243.2: day 1583.2: day 1833.2: day 2143.2: day 2473.2: day 2803.2: day 3343.2: day 3673.2: day 3953.2: day 4344.14.1: day 04.1: day 324.1: day 614.1: day 934.1: day 1254.1: day 2204.1: day 2434.1: day 2954.1: day 5245.25.2: day 05.2: day 1485.2: day 2785.2: day 4085.2: day 4325.2: day 4596.16.1: day 06.1: day 286.1: day 526.1: day 866.1: day 1197.27.2: day 07.2: day 297.2: day 747.2: day 1077.2: day 1297.2: day 1557.2: day 1877.2: day 2787.2: day 3097.2: day 4017.2: day 4307.2: day 4938.18.1: day 08.1: day 318.1: day 668.1: day 978.1: day 1248.1: day 1538.1: day 2178.1: day 2438.1: day 2768.1: day 3268.1: day 3448.1: day 3728.1: day 4449.19.1: day 09.1: day 619.1: day 999.1: day 1279.1: day 1889.1: day 2219.1: day 2519.1: day 3169.1: day 4129.1: day 4359.1: day 482case1case1: day 0case1: day 90case1: day 129case1: day 178case1: day 219case1: day 325case2case2: day 0case2: day 25case2: day 32case2: day 82case2: day 110case2: day 153case2: day 188case2: day 216case2: day 248case2: day 291case3case3: day 0case3: day 37case3: day 124case3: day 155case3: day 194case3: day 220case3: day 252case3: day 284case3: day 317case3: day 348case3: day 381case3: day 404case3: day 438case4case4: day 0case4: day 31case4: day 83case4: day 129case4: day 171case4: day 269case4: day 301case4: day 566case5case5: day 0case5: day 148case5: day 272case5: day 393case5: day 424case5: day 455case6case6: day 0case6: day 13case6: day 49case6: day 105case6: day 136case7case7: day 0case7: day 73case7: day 100case7: day 123case7: day 158case7: day 199case7: day 221case7: day 255case7: day 286case7: day 316case7: day 348case7: day 379case7: day 405case8case8: day 0case8: day 20case8: day 53case8: day 82case8: day 112case8: day 139case8: day 174case8: day 202case8: day 300case8: day 326case8: day 353case8: day 379case8: day 426case8: day 450case8: day 482case8: day 502case9case9: day 0case9: day 62case9: day 109case9: day 139case9: day 219case9: day 255case9: day 281case9: day 318case9: day 409case9: day 427case9: day 4670 d5 mo9 mo14 mo19 mo

Each row is one person (18 shown of 22); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category169 77%
country220 100%220
health_condition220 100%220
subject_id220 100%220
diet220 100%220
health_condition_detail220 100%220
sex220 100%220
timepoint_label220 100%220
age_at_collection_days169 77%169
Papers (2)
  • A metagenomic catalog of the early-life human gut virome. PMID 38424077 PMC10904392 curated
  • A meta-analysis of infant gut viromes reveals global patterns in bacteriophage community assembly and functional capacity over the first three years of life. PMID 42315844 PMC13434738 curated
Details
Archive description

The goal of this study is to determine if the enteric virome is altered in children who develop diabetes.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of child and infant / toddler by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage verdict include”
  • body site study.title · “Intestinal Virome Changes Precede”
  • body site external_curation.infant_catalog · “infant triage verdict include (gut/stool scope)”
  • life stage study.title · “I Diabetes Susceptible Children”
  • life stage study.description · “is altered in children who develop diabetes.”
  • life stage external_curation.infant_catalog · “infant triage verdict include (0-3 y scope)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN07163334age_at_collection_days120.0R10.85biosample.attribute:Age_at_Collection120
SAMN07163334countryFIR10.90biosample_attrFinland: Jorvi
SAMN07163334dietother_dietR20.85paper.supp.41467_2024_45793_MOESM4_ESM.xlsx[Sheet1!Feed]combined
SAMN07163334health_conditionhealthy_controlR20.75external.gmrepo sourcephenotype: Health
SAMN07163334health_condition_detailHealthR20.75external.gmrepo sourcephenotype: Health
SAMN07163334sexfemaleR20.75external.gmrepo sourcesex: Female
SAMN07163334subject_id1.1R10.70sample.name_rule:sample_id1.1_120
SAMN07163334timepoint_label6R20.85paper.supp.fig2b_vlp.xlsx[Sheet1!period]6
Sequencing

220 runs over 220 samples · mean 0.48 Gbp per run (median 0.47 Gbp, total 106.39 Gbp; 220 runs with a base count) · layout PAIRED 220 · platform ILLUMINA 220 · models Illumina MiSeq (220) · 0% of runs with a Sandpiper profile · first public 2017-06-23 – 2018-06-02

Authors (14)

Zeng S first · Almeida A · Li S · Ying J · Wang H · Qu Y · Paul Ross R · Stanton C · Zhou Z · Niu X · Mu D · Wang S last · Shamash M first · Maurice CF last

Downloads

PRJNA387903.csv.gz (7.3 KB) · parquet (80.1 KB) — all 220 samples, every field with route and confidence · PRJNA387903_determinations.csv.gz (13.7 KB) — 1,709 evidence rows

Samples (220 · every field this project has values for · hover a cell for its source)
Loading the sample table…